Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

McGill University

$44,461.00

Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness

EF 2017-18

Résumé
Due to the ageing world population, techniques to replace, restore, or regenerate bone havebecome a major clinical need in the fields of orthopaedic, spinal, dental, cranial, andmaxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgicaltreatment remains a major challenge. Traditional bone grafting techniques have performancelimitations including donor site morbidity, viral transmission, immunologic incompatibility, longrehabilitation time and structural failure. The need for new strategies for the treatment of bonedefects is therefore urgent. The ideal bone graft material must: (i) match the mechanicalproperties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degradeover time to be replaced by healthy bone. To this day, there is no synthetic material that canfulfill these three requirements simultaneously. In this project we will develop a new structuralbone graft made from calcium sulfate, collagen and gelatin. All components of this materialare fully biocompatible and FDA-approved for use as biomaterials. The mineral contentprovides stiffness, while the weaker protein layers can deflect incoming cracks to generatetoughness. The implication is that this material can be used to fabricate load-carrying grafts,as opposed to traditional calcium phosphates/sulfates which are too brittle. The structuralbone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated withan animal study. In addition, bone grafts with complex patient-specific shapes will bedeveloped using 3D printed polymeric templates. This new medical technology will have asignificant impact on restoring functionality and quality of life in patients requiringreconstruction of structural bone defects secondary to trauma, failed arthroplasties, bonetumors, maxillofacial surgery or other bone diseases.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
508413-2017
Name nom
Barthelat, Francois
Department département
Mechanical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
44461
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness
Keyword
NSERC
Application summary
Due to the ageing world population, techniques to replace, restore, or regenerate bone havebecome a major clinical need in the fields of orthopaedic, spinal, dental, cranial, andmaxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgicaltreatment remains a major challenge. Traditional bone grafting techniques have performancelimitations including donor site morbidity, viral transmission, immunologic incompatibility, longrehabilitation time and structural failure. The need for new strategies for the treatment of bonedefects is therefore urgent. The ideal bone graft material must: (i) match the mechanicalproperties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degradeover time to be replaced by healthy bone. To this day, there is no synthetic material that canfulfill these three requirements simultaneously. In this project we will develop a new structuralbone graft made from calcium sulfate, collagen and gelatin. All components of this materialare fully biocompatible and FDA-approved for use as biomaterials. The mineral contentprovides stiffness, while the weaker protein layers can deflect incoming cracks to generatetoughness. The implication is that this material can be used to fabricate load-carrying grafts,as opposed to traditional calcium phosphates/sulfates which are too brittle. The structuralbone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated withan animal study. In addition, bone grafts with complex patient-specific shapes will bedeveloped using 3D printed polymeric templates. This new medical technology will have asignificant impact on restoring functionality and quality of life in patients requiringreconstruction of structural bone defects secondary to trauma, failed arthroplasties, bonetumors, maxillofacial surgery or other bone diseases.